Targeting of Mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer
Preprint in Research Square (March 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Preprint in Research Square (March 2024)
Article in Cancer Cell International (March 2024)
Article in npj Precision Oncology (January 2024)